🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Randomized, placebo-controlled trial with a 2x2 factorial design testing th...
Status
Completed
Location
Children's Hospital of Philadelphia
Start Date
2020-09-03
Trial ID
NCT04192136
Treatments Being Tested
RIFAstrat is a Phase 3, double-blind, placebo-controlled, non-inferiority t...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-02-01
Trial ID
NCT07118696
Treatments Being Tested
In 2008 Goker et al, introduced Ankaferd Blood Stopper (ABS) as a new hemos...
Status
Unknown
Location
Acibadem University
Start Date
2016-11
Trial ID
NCT02982733
There is a marked and long-lasting improvement in glucose homeostasis that ...
Status
Completed
Location
Washington University School of Medicine
Start Date
2014-07
Trial ID
NCT02204813
Treatments Being Tested
Vitiligo is a disease in which autoimmunity plays a major role. Multiple tr...
Status
Unknown
Location
Ain Shams University
Start Date
2018-11-01
Trial ID
NCT04030988
Treatments Being Tested
n Canada, over 60% of adults are classified as overweight and obese resulti...
Status
Unknown
Location
Concordia University
Start Date
2024-07-05
Trial ID
NCT06487234
Treatments Being Tested
This is a Phase 2b, randomized, double blind, parallel group, multicenter s...
Status
Completed
Location
Marvel Research, LLC
Start Date
2018-11-26
Trial ID
NCT03715829
The current study will investigate the effects of Blood Flow Restriction (B...
Status
Completed
Location
University of Mary Hardin-Baylor
Start Date
2019-09-04
Trial ID
NCT04079010
Treatments Being Tested
The purpose of this study is to better understand the neural correlates of ...
Status
Recruiting
Location
Imaging Research Center
Start Date
2021-04-14
Trial ID
NCT04885322
Treatments Being Tested
This is a phase 4 trial evaluating the clinical effect of combining a place...
Status
Completed
Location
Austin Institute for Clinical Research, Inc.
Start Date
2023-11-14
Trial ID
NCT06090071
Treatments Being Tested